Results 141 to 150 of about 901 (171)

Reduced exposure to darunavir and cobicistat in HIV‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen

HIV Medicine, 2019
Herta Crauwels
exaly  

Cobicistat/darunavir/dolutegravir

Reactions Weekly, 2018
openaire   +1 more source

Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection

Pharmacotherapy, 2013
Jason J Schafer, James Priano, Kathleen E Squires   +2 more
exaly  

Cobicistat/darunavir/emtricitabine/tenofovir

Reactions Weekly, 2020
openaire   +1 more source

Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV

Expert Opinion on Drug Metabolism and Toxicology, 2019
Dario Cattaneo, Maria Vittoria Cossu, Giuliano Rizzardini   +2 more
exaly  

Cobicistat/Salmeterol/fluticasone-propionate

Reactions Weekly, 2023
openaire   +1 more source

Cobicistat-Boosted Protease Inhibitors in HIV-Infected Patients with Mild to Moderate Renal Impairment

HIV Clinical Trials, 2014
Moti Ramgopal, Frank A Post, Joseph Custódio   +2 more
exaly  

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

ACS Medicinal Chemistry Letters, 2010
Bernard P Murray, Allen Y Hong, Manoj C Desai   +2 more
exaly  

Pharmacokinetic Differences Between Cobicistat and Ritonavir on Warfarin

Annals of Pharmacotherapy, 2018
Patricia, Pecora Fulco, Laura Hill, Bannister   +1 more
openaire   +2 more sources

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV‐1‐infected subjects with dyslipidaemia

HIV Medicine, 2017
E Negredo
exaly